Lenacapavir for HIV-1 - Potential Promise of a Long-Acting Antiretroviral Drug

N Engl J Med. 2022 May 12;386(19):1848-1849. doi: 10.1056/NEJMe2204376.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anti-HIV Agents* / therapeutic use
  • Anti-Retroviral Agents / therapeutic use
  • HIV Infections* / drug therapy
  • HIV-1*
  • Humans

Substances

  • Anti-HIV Agents
  • Anti-Retroviral Agents